New Key Statistics Module, Z-Score and F-Score
HKSE:08622 Key Ratios
Market Cap HK$ M | 75.07 |
Enterprise Value HK$ M | 40.68 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.25 |
Price/Sales | 2.27 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 27.00 |
EPS (TTM) HK$ | -0.02 |
Beneish M-Score | -3.36 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -6.49 |
EV-to-EBITDA | -6.49 |
PEG | -- |
Shares Outstanding M | 500.47 |
Net Margin (%) | -23.37 |
Operating Margin % | -27.22 |
Pre-tax Margin (%) | -23.36 |
Quick Ratio | 5.51 |
Current Ratio | 5.82 |
ROA % (ttm) | -8.89 |
ROE % (ttm) | -10.75 |
ROIC % (ttm) | -25.99 |
Dividend Yield % | -- |
Altman Z-Score | 5.59 |
HKSE:08622 Number of Guru Trades
HKSE:08622 Volume of Guru Trades
Gurus Latest Trades with HKSE:08622
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:08622 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Huakang Biomedical Holdings Co Ltd Insider Transactions
No Available Data